Pershing sells 3.4M shares of Valeant shares

Pershing Square Capital Management sold more than 3.4 million shares of Valeant Pharmaceuticals on Tuesday for The Pershing Square and [Read More]
To access this content, you must be a member. Visit the Plans page for details.